web-based bioarray software environment (base) system (Bioarray Inc)
90
Structured Review
Bioarray Inc
web-based bioarray software environment (base) system
Web Based Bioarray Software Environment (Base) System, supplied by Bioarray Inc, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/web-based+bioarray+software+environment+(base)/bioarray+software/pmc05549301-120-18-19
Average 90 stars, based on 1 article reviews
Web Based Bioarray Software Environment (Base) System, supplied by Bioarray Inc, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/web-based+bioarray+software+environment+(base)/bioarray+software/pmc05549301-120-18-19
Average 90 stars, based on 1 article reviews
web-based bioarray software environment (base) system - by Bioz Stars,
2026-09
90/100 stars
Images
Related Articles
other:Article Title: Global transcriptomic response of Leptospira interrogans serovar Copenhageni upon exposure to serum Article Snippet: The Article Title: Transcriptional Response of Leptospira interrogans to Iron Limitation and Characterization of a PerR Homolog Article Snippet: Raw data from the comparisons were analyzed using the Article Title: Gain of chromosomal region 20q and loss of 18 discriminates between Lynch syndrome and familial colorectal cancer. Article Snippet: 2012 E 2012.11.0 ess: Clin Kettegå . gmail.co Abstract Lynch syndrome and familial colorectal cancer type X, FCCTX, represent the two predominant colorectal cancer syndromes.. Whereas Lynch syndrome is clinically and genetically well defined, the genetic cause of FCCTX is unknown and genomic differences between Lynch syndrome and FCCTX tumours are largely unknown.. We applied array-based comparative genomic hybridisation to 23 colorectal cancers from FCCTX with comparison to 23 Lynch syndrome tumours and to 45 sporadic colorectal cancers. Article Title: Differential gene expression in human fibroblasts after alpha-particle emitter (211)At compared with (60)Co irradiation. Article Snippet: Th e clinical use of high linear energy transfer (high-LET) irradiation such as targeted alpha therapy and external ion beam therapy (Brechbiel 2007, Jakel et al. 2008) has increased during recent years.. High-LET irradiation possesses several biological and physical properties which warrant its further clinical use (Sgouros et al. 2010).. In contrast to radioimmunotherapy (RIT) using β -particle emitters, α -RIT has emerged as a potentially attractive treatment alternative of residual micrometastases due to short track lengths with a mean range in tissue of 50 – 100 μ m. Th is allows the high energy of the α -particles to be deposited mainly in targeted cells. Article Title: Hedgehog inhibitor sonidegib potentiates 177 Lu-octreotate therapy of GOT1 human small intestine neuroendocrine tumors in nude mice Article Snippet: In the transcriptional analysis, data pre-processing and quantile normalization were performed on the raw signal intensities using the Article Title: Potential Biomarkers for Radiation-Induced Renal Toxicity following 177 Lu-Octreotate Administration in Mice Article Snippet: The Article Title: Transcriptional response of kidney tissue after 177Lu-octreotate administration in mice. Article Snippet: Data preprocessing and quantile normalization of raw signal intensities were conducted through the use of the Article Title: Characterization of a hotspot region on chromosome 12 for amplification in ring chromosomes in atypical lipomatous tumors. Article Snippet: Ring chromosomes are cytogenetic hallmarks of genomic amplification in several bone and soft tissue tumors, in particular atypical lipomatous tumors (ALT).. In ALT, the ring chromosomes invariably contain amplified material from the central part of the long arm of chromosome 12, mainly 12q12!15, but often also segments from other chromosomes are involved.. Previous studies have shown that one of the recurrent amplicons in ALT, located in 12q13.3-14.1 and harboring the candidate target genes TSPAN31 and CDK4, often has a sharp centromeric border. |